Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Barrett

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Blood|November 9, 2019
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cellsMarco Ruella, David M Barrett, Olga Shestova, et al.
Cancer Immunology Research|February 25, 2014
iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo Hamid Bassiri, Rupali Das, Peng Guan, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Molecular and Cellular Biology|August 15, 2018
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic ReticulumAsen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Molecular and Cellular Biology|August 17, 2022
Correction for Bagashev et al., "CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum"Asen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Cell Discovery|November 28, 2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine releaseYiyang Xu, Zhiyuan Yang, Lucas H Horan, et al.
Annals of Neurology|September 5, 2018
Neurotoxicity after CTL019 in a pediatric and young adult cohortJacqueline S Gofshteyn, Pamela A Shaw, David T Teachey, et al.
Human Gene Therapy|July 20, 2018
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell ResponseJessica B Foster, Namrata Choudhari, Jessica Perazzelli, et al.
Cancer Discovery|April 6, 2021
Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell TherapyGregory M Chen, Changya Chen, Rajat K Das, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.
Blood|November 9, 2019
A cellular antidote to specifically deplete anti-CD19 chimeric antigen receptor-positive cellsMarco Ruella, David M Barrett, Olga Shestova, et al.
Cancer Immunology Research|February 25, 2014
iNKT cell cytotoxic responses control T-lymphoma growth in vitro and in vivo Hamid Bassiri, Rupali Das, Peng Guan, et al.
Journal for Immunotherapy of Cancer|May 19, 2021
Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cellsZhiliang Bai, Stefan Lundh, Dongjoo Kim, et al.
Molecular and Cellular Biology|August 15, 2018
CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic ReticulumAsen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Molecular and Cellular Biology|August 17, 2022
Correction for Bagashev et al., "CD19 Alterations Emerging after CD19-Directed Immunotherapy Cause Retention of the Misfolded Protein in the Endoplasmic Reticulum"Asen Bagashev, Elena Sotillo, Chih-Hang Anthony Tang, et al.
Cell Discovery|November 28, 2018
A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine releaseYiyang Xu, Zhiyuan Yang, Lucas H Horan, et al.
Annals of Neurology|September 5, 2018
Neurotoxicity after CTL019 in a pediatric and young adult cohortJacqueline S Gofshteyn, Pamela A Shaw, David T Teachey, et al.
Human Gene Therapy|July 20, 2018
Purification of mRNA Encoding Chimeric Antigen Receptor Is Critical for Generation of a Robust T-Cell ResponseJessica B Foster, Namrata Choudhari, Jessica Perazzelli, et al.
Cancer Discovery|April 6, 2021
Integrative Bulk and Single-Cell Profiling of Premanufacture T-cell Populations Reveals Factors Mediating Long-Term Persistence of CAR T-cell TherapyGregory M Chen, Changya Chen, Rajat K Das, et al.
Pageof 8